de la Haba-Rodriguez, JuanLloret, Ferran FerragutSalgado, Maria Angeles VazArce, Marin OreGutierrez, Ana CardeñaJimenez, Jesus Garcia-DonasZambrano, Carmen BeatoAlonso, Rosa Maria RodriguezLopez, Rafael LopezSalas, Nuria Rodriguez2023-05-032023-05-032022-02-22de la Haba-Rodriguez J, Lloret FF, Salgado MAV, Arce MO, Gutiérrez AC, Jiménez JG, et al. SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021). Clin Transl Oncol. 2022 Apr;24(4):693-702http://hdl.handle.net/10668/21141The improvement of molecular alterations in cancer as well as the development of technology has allowed us to bring closer to clinical practice the determination of molecular alterations in the diagnosis and treatment of cancer. The use of multidetermination platforms is spreading in most Spanish hospitals. The objective of these clinical practice guides is to review their usefulness, and establish usage guidelines that guide their incorporation into clinical practice.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/BiomarkersMolecular platformsNext-generation sequencingPrecision medicineÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de CádizNeoplasmsHospitalsTechnologyresearch article35362851open accessHospitalesNeoplasiasTecnología10.1007/s12094-022-02817-81699-3055PMC8986692https://link.springer.com/content/pdf/10.1007/s12094-022-02817-8.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986692/pdf